Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance

Molecular Genetics and Metabolism Reports - Tập 25 - Trang 100671 - 2020
M. Kreile1,2, O. Lubina2, I. Ozola-Zalite2, R. Lugovska2, N. Pronina2, O. Sterna2, P. Vevere2, M. Konika2, I. Malniece2, L. Gailite1
1Riga Stradins University, Dzirciema Street 16, Riga LV-1007, Latvia
2Children's Clinical University Hospital, Vienibas gatve 46, Riga LV-1004, Latvia

Tài liệu tham khảo

Al Hafid, 2015, Phenylketonuria: a review of current and future treatments, Transl. Pediatr., 4, 304

Birk Møller, 2007, Low proportion of whole exon deletions causing phenylketonuria in Denmark and Germany, Hum. Mutat., 28, 207, 10.1002/humu.9481

Blau, 2016, Genetics of phenylketonuria: then and now, Hum. Mutat., 37, 508, 10.1002/humu.22980

Blau, 2010, Phenylketonuria, Lancet (London, England), 376, 1417, 10.1016/S0140-6736(10)60961-0

Clark, 2019, Ten-year retrospective review (2003−2013) of 56 inpatient admissions to stabilize elevated phenylalanine levels, JIMD Rep., 46, 70, 10.1002/jmd2.12019

Gundorova, 2019, Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia, PLoS One, 14, 10.1371/journal.pone.0211048

Jurecki, 2017, Adherence to clinic recommendations among patients with phenylketonuria in the United States, Mol. Genet. Metab., 120, 190, 10.1016/j.ymgme.2017.01.001

Kasnauskiene, 2003, The molecular basis of phenylketonuria in Lithuania, Hum. Mutat., 21, 398, 10.1002/humu.9113

Kopanos, 2019, VarSome: the human genomic variant search engine, Bioinformatics (Oxford, England), 35, 1978, 10.1093/bioinformatics/bty897

Landrum, 2018, ClinVar: improving access to variant interpretations and supporting evidence, Nucleic Acids Research, 46, D1062, 10.1093/nar/gkx1153

Lilleväli, 2019, The evaluation of phenylalanine levels in Estonian phenylketonuria patients during eight years by electronic laboratory records, Mol. Genet. Metab. Rep., 19, 100467, 10.1016/j.ymgmr.2019.100467

Lilleväli, 2018, Hyperphenylalaninaemias in Estonia: genotype-phenotype correlation and comparative overview of the patient cohort before and after nation-wide neonatal screening, JIMD Rep., 40, 39, 10.1007/8904_2017_61

MacDonald, 2010, The reality of dietary compliance in the management of phenylketonuria, J. Inherit. Metab. Dis., 33, 665, 10.1007/s10545-010-9073-y

Pronina, 2003, The molecular basis of phenylketonuria in Latvia, Hum. Mutat., 21, 398, 10.1002/humu.9114

Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet. Med., 17, 405, 10.1038/gim.2015.30

Su, 2019, The molecular epidemiology of hyperphenylalaninemia in Uygur population: incidence from newborn screening and mutational spectra, Ann. Transl. Med., 7, 258, 10.21037/atm.2019.05.16

van Wegberg, 2017, The complete European guidelines on phenylketonuria: diagnosis and treatment, Orphanet J. Rare Dis., 12, 162, 10.1186/s13023-017-0685-2

Vieira Neto, 2019, Genotype-phenotype correlations and BH(4) estimated responsiveness in patients with phenylketonuria from Rio de Janeiro, Southeast Brazil, Mol. Genet. Genomic Med., 7, e610, 10.1002/mgg3.610

Thông tin
Thông tin xuất bản

Molecular Genetics and Metabolism Reports

Tập 25

100671

Thông tin tác giả